Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. doi:10.1002/ijc.25516.
   PubMed Web of Science ®Google Scholar
• Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 7;2008:237–257.
   PubMed Web of Science ®Google Scholar
• Tiong L, Maddern GJ. 2011. Systematic review and meta‐analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 98:1210–1224. doi:10.1002/bjs.7669.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Marrero JA, Rudolph L and Reddy KR. 2008. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 134:1752. doi:10.1053/j.gastro.2008.01.074.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. 2008. Cancer cell metabolism: warburg and beyond. Cell. 134:703–707. doi:10.1016/j.cell.2008.08.021.
   PubMed Web of Science ®Google Scholar
• Heiden MGV, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 324:1029. doi:10.1126/science.1160809.
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 123;1956:309–314.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Hatano E, Higashi T, Narita M, Seo S, Nakamoto Y, Yamanaka K, Nagata H, Taura K, Yasuchika K, et al. 2011. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol. 55:846–857. doi:10.1016/j.jhep.2011.01.038.
   PubMed Web of Science ®Google Scholar
• Beyo D, F X L, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Jf D, Jr I. 2013. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology. 58:229–238. doi:10.1002/hep.26350.
   PubMed Web of Science ®Google Scholar
• Beyoğlu D, Idle JR. 2013. The metabolomic window into hepatobiliary disease. J Hepatol. 59:842–858. doi:10.1016/j.jhep.2013.05.030.
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. 2004. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. doi:10.1038/nrc1478.
   PubMed Web of Science ®Google Scholar
• Dong G, Mao Q, Xia W, Youtao XU, Wang J, Lin XU, Jiang F. 2016. PKM2 and cancer: the function of PKM2 beyond glycolysis. Oncol Lett. 11:1980. doi:10.3892/ol.2016.4099.
   PubMed Web of Science ®Google Scholar
• Wei L, Yang C, Zhang Y, Sheng L, Jian G, Xuan W, Mu J, Hu YP, Lin J, Ping D. 2016. Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer. Sci Rep. 6:26351. doi:10.1038/srep26351.
   PubMed Web of Science ®Google Scholar
• Zhang HS, Zhang FJ, Li H, Liu Y, Du GY and Huang YH. 2016. Tanshinone ⅡA inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation. Arch Biochem Biophys. 598:50–56. doi:10.1016/j.abb.2016.03.031.
   PubMed Web of Science ®Google Scholar
• Liang J, Cao R, Zhang Y, Xia Y, Zheng Y, Li X, Wang L, Yang W, Lu Zand Yang W et al. 2016. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nat Commun. 7:12431. doi:10.1038/ncomms12431.
   PubMed Web of Science ®Google Scholar
• Salmena L, Carracedo A and Pandolfi PP. 2008. Tenets of PTEN tumor suppression. Cell. 133:403. doi:10.1016/j.cell.2008.04.013.
   PubMed Web of Science ®Google Scholar
• Hong SY, Yu FX, Luo Y and Hagen T. 2016. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal. 28:377–383. doi:10.1016/j.cellsig.2016.01.011.
   PubMed Web of Science ®Google Scholar
• Simonassmann P. 2013. The laminin family: founding members of the basement membrane. Cell Adh Migr. 7:44. doi:10.4161/cam.23276.
   PubMed Web of Science ®Google Scholar
• Givant-Horwitz V, Davidson B, Reich R. 2005. Laminin-induced signaling in tumor cells. Cancer Lett. 223:1. doi:10.1016/j.canlet.2004.08.030.
   PubMed Web of Science ®Google Scholar
• Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol. 2002;12(3):197–207. doi:10.1016/S1044-579X(02)00023-8.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M. 2017. Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma. J Cancer. 8:2992. doi:10.7150/jca.21038.
   PubMed Web of Science ®Google Scholar
• Yang ZP, Ma HS, Wang SS, Wang L, Liu T. 2017. LAMC1 mRNA promotes malignancy of hepatocellular carcinoma cells by competing for MicroRNA-124 binding with CD151. IUBMB Life. 69:595. doi:10.1002/iub.1642.
   PubMed Web of Science ®Google Scholar
• Hong JY, Kang B, Kim A, Hwang S, Ahn J, Lee S, Kim J, Jh P, Ds C. 2011. Development of a highly sensitive real-time one step RT-PCR combined complementary locked primer technology and conjugated minor groove binder probe. Virol J. 8:1–6. doi:10.1186/1743-422X-8-1.
   PubMed Web of Science ®Google Scholar
• Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 8;1927:519–530.
   PubMedGoogle Scholar
• Braun AC. On the origin of the cancer cells. Am Sci. 58;1970:307–320.
   PubMed Web of Science ®Google Scholar
• Han MW, Lee HJ, Cho KJ, Kim JS, Roh JL, Choi SH, Sy N, Sy K. 2012. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head Neck. 34:1395–1402. doi:10.1002/hed.21945.
   PubMed Web of Science ®Google Scholar
• Yan SX, Luo XM, Zhou SH, Bao YY, Fan J, Lu ZJ, Liao XB, Huang YP, Tt W, Qy W. 2013. Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma. Int J Med Sci. 10:1375–1386. doi:10.7150/ijms.6855.
   PubMed Web of Science ®Google Scholar
• Cui J, Shi M, Xie D, Wei D, Jia Z, Zheng S, Gao Y, Huang S, Xie K. 2014. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Clin Cancer Res. 20:2595–2606. doi:10.1158/1078-0432.CCR-13-2407.
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Gz C. 2009. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal. 2:ra73. doi:10.1126/scisignal.2000431.
   PubMed Web of Science ®Google Scholar
• Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A. 2012. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol. 8:839–847. doi:10.1038/nchembio.1060.
   PubMed Web of Science ®Google Scholar
• Stefaniuk P, Janusz C, Wiercinska-Drapalo A. 2010. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 16:418. doi:10.3748/wjg.v16.i4.418.
   PubMed Web of Science ®Google Scholar
• Zee JAVD, Eijck CHV, Hop WC, Biermann K, Dicheva BM, Seynhaeve AL, Koning GA, Am E, Tlt H. 2012. Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer. Br J Cancer. 107:1153–1158. doi:10.1038/bjc.2012.373.
   PubMed Web of Science ®Google Scholar
• Heiden MGV, Lc C, Cb T. 2009. Understanding the Warburg Effect: the metabolic requirements of cell proliferation. Science. 324:1029. doi:10.1126/science.1160809.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, Wei C, Guo F, Chen Y. 2014. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell. 53:75–87. doi:10.1016/j.molcel.2013.11.001.
   PubMed Web of Science ®Google Scholar
• Iansante V, Choy PM, Fung SW, Liu Y, Chai JG, Dyson J, Rio AD, D’Santos C, Williams R, Chokshi S. 2015. PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nat Commun. 6:7882. doi:10.1038/ncomms8882.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Lin Z, Xu J, Lu Y, Meng Q, Wang C, Yang Y, Xin X, Li X, Pu H, et al. 2018. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN. Cell Death Dis. 9:253. doi:10.1038/s41419-018-0305-7.
   PubMed Web of Science ®Google Scholar
• Yang L, Hou Y, Yuan J, Tang S, Zhang H, Zhu Q, Du Y, Zhou M, Wen S, Xu L, et al. 2015. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Oncotarget. 6:25755–25769. doi:10.18632/oncotarget.4697.
   PubMedGoogle Scholar
• Kong L, Schäfer G, Bu H, Zhang Y, Zhang Y, Klocker H. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Eur Urol Suppl. 11;2012:751.
   Web of Science ®Google Scholar
• Tang Y, Lv P, Sun Z, Han L, Zhou W. 2016. 14-3-3β promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3K/Akt/NF-κB pathway. PLoS One. 11:e0146070. doi:10.1371/journal.pone.0146070.
   PubMed Web of Science ®Google Scholar